InvestorsHub Logo
icon url

loanranger

09/20/22 9:13 PM

#393470 RE: williamssc #393466

"My opinion if Brilacidin meets it's potential as a broad-spectrum antiviral it may likely win approval in this current climate."

Will there be clinical trials first and if so for which indication? Or will the Approval Fairy just swoop down and wave her magic wand over B-bs?